Back

Definitive Healthcare Corp

Ticker: DH ISIN: US24477E1038
Add to portfolio Portfolio analysis in 2min
Stock Small-cap High beta
Market cap
$538.34M
Forward P/E
15.04
Profit margin
-1.42%
Revenue growth QoQ
-4.00%
Beta
1.33
$0.72 0.97%
Price as of 2026-08-24 · NASDAQ

Performance by timeframe

Rolling returns
1 Month +6.96%
6 Months -48.14%
1 Year -81.93%
5 Years -55.94% p.a.-98.33%
Since inception -56.36% p.a.-98.33%
Calendar year returns
YTD -74.88%
2025 -30.17%
2024 -58.65%
2023 -9.55%
2022 -59.79%

Key stats

Market cap
538.34M
Beta
1.33
52-week range
3.19 - 10.62
50-day MA
4.38
200-day MA
5.58
Section 1

Business overview

Company profile data from fundamentals.

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate firms, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.

Sector Healthcare
Industry Health Information Services
Country United States
Exchange NASDAQ
Section 2

Financial quality

Above-average volatility

Profitability and balance-sheet quality indicators from reported fundamentals.

Profitability

ROE -54.78%
ROA -0.76%
Profit margin -1.42%
Operating margin 1.26%
Revenue/share TTM 2.19
Revenue TTM 255.85M
EBITDA 33.21M
Gross profit TTM 196.79M
Beta 1.33

Valuation

Trailing P/E 0.00
Forward P/E 15.04
P/B 1.06
P/S 2.10
EV/EBITDA 46.69
EV/Revenue 1.92
Section 3

Earnings

Earnings metrics from company highlights and earnings datasets.

EPS estimate (current year) 0.34
Quarterly earnings growth 0.00%
Revenue TTM 255.85M
Reported quarters 19
Section 4

Dividends & corporate actions

Dividend and split fields from fundamentals.

Forward annual div. yield 0.00%
Last split date 0000-00-00
Section 5

Ownership / analyst view

Institutional ownership and analyst estimate fields when available.

Analyst

Analyst target price $12.45
Analyst rating 3.5385

Ownership & short interest

Shares outstanding 115.52M
Shares float 44.35M
Institutional ownership 95.38%
Insider ownership 3.87%
Short ratio 6.31
Short % of float 5.20%

Details

Instrument metadata and source update timestamps.

Symbol DH
Name Definitive Healthcare Corp
Asset type STOCK
Exchange NASDAQ
Currency USD
ISIN US24477E1038
Country USA
Code + exchange DH.NASDAQ
Fundamentals updated 2024-12-08

The information provided on this platform is for informational purposes only and should not be considered as financial or investment advice. Insightfolio does not provide investment advice, personalized recommendations, or guidance regarding the purchase, holding, or sale of financial assets. The tools and content are intended for educational purposes only and are not tailored to individual circumstances, financial needs, or objectives.

Insightfolio assumes no liability for the accuracy, completeness, or reliability of the information presented. Users are solely responsible for verifying the information and making independent decisions based on their own research and careful consideration. Use of the platform should not replace consultation with qualified financial professionals.

Investments involve risks. Users should be aware that the value of investments may fluctuate and that past performance is not an indicator of future results. Investment decisions should be based on personal financial goals, risk tolerance, and independent evaluation of relevant information.

Insightfolio does not endorse or guarantee the suitability of any particular financial product, security, or strategy. Any projections, forecasts, or hypothetical scenarios presented on the platform are for illustrative purposes only and are not guarantees of future outcomes.

By accessing the services, information, or content offered by Insightfolio, users acknowledge and agree to these terms of the disclaimer. If you do not agree to these terms, please do not use our platform.

Instrument logos provided by Elbstream.